{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:18:19Z","timestamp":1792840699752,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1378\/chest.08-3043","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T22:29:29Z","timestamp":1254868169000},"page":"1101-1111","source":"Crossref","is-referenced-by-count":87,"title":["Antineutrophil Cytoplasmic Antibody-Associated Vasculitides and Respiratory Disease"],"prefix":"10.1016","volume":"136","author":[{"given":"Jose A.","family":"G\u00f3mez-Puerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"L\u00f3pez-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-3043_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1378\/chest.07-0769","article-title":"Dr. Friedrich Wegener, the ACCP, and history","volume":"132","author":"Rosen","year":"2007","journal-title":"Chest"},{"key":"10.1378\/chest.08-3043_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","article-title":"Antineutrophil cytoplasmic antibodies","volume":"368","author":"Bosch","year":"2006","journal-title":"Lancet"},{"key":"10.1378\/chest.08-3043_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1191\/096120398678920055","article-title":"Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome","volume":"7","author":"Lhote","year":"1998","journal-title":"Lupus"},{"key":"10.1378\/chest.08-3043_bib5","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.08-3043_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1681\/ASN.2005101048","article-title":"Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies","volume":"17","author":"Jennette","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1378\/chest.08-3043_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/BOR.0b013e3280119842","article-title":"Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis","volume":"19","author":"Kallenberg","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1378\/chest.08-3043_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","article-title":"Membrane expression of proteinase 3 is genetically determined","volume":"14","author":"Schreiber","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1378\/chest.08-3043_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1523-1755.2005.00063.x","article-title":"ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation","volume":"67","author":"Tse","year":"2005","journal-title":"Kidney Int"},{"key":"10.1378\/chest.08-3043_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","article-title":"Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides","volume":"2","author":"Kallenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1378\/chest.08-3043_bib11","first-page":"S35","article-title":"New developments in the pathogenesis of ANCA-associated vasculitis","volume":"21","author":"Day","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1378\/chest.08-3043_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.08-3043_bib13","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"10.1378\/chest.08-3043_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","article-title":"Antimyeloperoxidase-associated lung disease: an experimental model","volume":"160","author":"Foucher","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.08-3043_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMp048338","article-title":"The spectrum of Wegener's granulomatosis and disease relapse","volume":"352","author":"Bacon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-3043_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940500921X","article-title":"Pathogenesis of Wegener's granulomatosis: current concepts","volume":"7","author":"Sarraf","year":"2005","journal-title":"Expert Rev Mol Med"},{"key":"10.1378\/chest.08-3043_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1361.042","article-title":"Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production","volume":"1051","author":"Voswinkel","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1378\/chest.08-3043_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1523-1755.2004.501_5.x","article-title":"CD28-T cells display features of effector memory T cells in Wegener's granulomatosis [letter]","volume":"65","author":"Lamprecht","year":"2004","journal-title":"Kidney Int"},{"key":"10.1378\/chest.08-3043_bib19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral blood and granuloma CD4(+)CD28(\u2212) T cells are a major source of interferon-\u03b3 and tumor necrosis factor-\u03b1 in Wegener's granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1378\/chest.08-3043_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1196\/annals.1381.003","article-title":"CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis","volume":"1107","author":"Abdulahad","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1378\/chest.08-3043_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2005.044909","article-title":"B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions","volume":"65","author":"Voswinkel","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.mnh.0000165886.93427.b1","article-title":"New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity","volume":"14","author":"Preston","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1378\/chest.08-3043_bib24","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/ndt\/gfh830","article-title":"ANCA-negative pauci-immune renal vasculitis: histology and outcome","volume":"20","author":"Eisenberger","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1378\/chest.08-3043_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1681\/ASN.V103499","article-title":"Prominence of cell-mediated immunity effectors in \u201cpauci-immune\u201d glomerulonephritis","volume":"10","author":"Cunningham","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1378\/chest.08-3043_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1017\/S0022215100129007","article-title":"Necrobacillosis: an unusual case of pharyngotonsillitis","volume":"108","author":"Carrie","year":"1994","journal-title":"J Laryngol Otol"},{"key":"10.1378\/chest.08-3043_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib28","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"10.1378\/chest.08-3043_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-3043_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rdc.2007.09.004","article-title":"Airway involvement in Wegener's granulomatosis","volume":"33","author":"Polychronopoulos","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1378\/chest.08-3043_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/BOR.0b013e3280119854","article-title":"Churg-Strauss syndrome","volume":"19","author":"Pagnoux","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1378\/chest.08-3043_bib32","first-page":"517","article-title":"Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage","volume":"118","author":"Bosch","year":"1994","journal-title":"Arch Pathol Lab Med"},{"issue":"suppl","key":"10.1378\/chest.08-3043_bib33","first-page":"S906","volume":"58","author":"Guillevin","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0025-6196(12)62575-0","article-title":"Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients","volume":"65","author":"Nada","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1378\/chest.08-3043_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcp\/104.1.7","article-title":"The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase","volume":"104","author":"Gaudin","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1378\/chest.08-3043_bib36","first-page":"166","article-title":"Pulmonary alveolitis as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil","volume":"27","author":"G\u00f3mez-Puerta","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1378\/chest.08-3043_bib37","first-page":"1224","article-title":"Outcome in small-vessel systemic vasculitis","volume":"33","author":"Luqmani","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-3043_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJMp030047","article-title":"Treatment of ANCA-associated vasculitis","volume":"349","author":"Langford","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-3043_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNF\u03b1 blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1378\/chest.08-3043_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.bor.0000200369.24793.f5","article-title":"Advances in the therapy of Wegener's granulomatosis","volume":"18","author":"Hellmich","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1378\/chest.08-3043_bib42","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jama.298.6.655","article-title":"Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review","volume":"298","author":"Bosch","year":"2007","journal-title":"JAMA"},{"key":"10.1378\/chest.08-3043_bib43","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","article-title":"Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients","volume":"87","author":"Chen","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1378\/chest.08-3043_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MAJ.0b013e31816805fa","article-title":"Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis","volume":"336","author":"Holguin","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1378\/chest.08-3043_bib46","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1378\/chest.06-2464","article-title":"Outcome of patients with small-vessel vasculitis admitted to a medical ICU","volume":"131","author":"Khan","year":"2007","journal-title":"Chest"},{"key":"10.1378\/chest.08-3043_bib47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/27.4.258","article-title":"Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients","volume":"27","author":"Guillevin","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis: Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-3043_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10157-004-0321-z","article-title":"A case of Wegener's granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP)","volume":"8","author":"Iwatani","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"10.1378\/chest.08-3043_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2169\/internalmedicine.46.6070","article-title":"Pulmonary-renal syndrome, diffuse pulmonary hemorrhage and glomerulonephritis, associated with Wegener's granulomatosis effectively treated with early plasma exchange therapy","volume":"46","author":"Sugimoto","year":"2007","journal-title":"Intern Med"},{"key":"10.1378\/chest.08-3043_bib51","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1378\/chest.08-3043_bib52","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/cc5132","article-title":"Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage","volume":"10","author":"Heslet","year":"2006","journal-title":"Crit Care"},{"key":"10.1378\/chest.08-3043_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1164\/ajrccm.166.9.267d","article-title":"Factor VIIa for alveolar hemorrhage in microscopic polyangiitis","volume":"166","author":"Betensley","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.08-3043_bib54","first-page":"1017","article-title":"Treatment of subglottic stenosis, due to Wegener's granulomatosis, with intralesional corticosteroids and dilation","volume":"30","author":"Hoffman","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib55","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/0961203308089693","article-title":"Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis","volume":"17","author":"Solans-Laque","year":"2008","journal-title":"Lupus"},{"key":"10.1378\/chest.08-3043_bib56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11926-006-0014-6","article-title":"Wegener's granulomatosis: is biologic therapy useful?","volume":"8","author":"Sarraf","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1378\/chest.08-3043_bib57","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1993.98","article-title":"In situ production of TNF-\u03b1, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis","volume":"43","author":"Noronha","year":"1993","journal-title":"Kidney Int"},{"key":"10.1378\/chest.08-3043_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","article-title":"Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-\u03b1","volume":"167","author":"Huugen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1378\/chest.08-3043_bib59","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","article-title":"Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial","volume":"54","author":"Stone","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-\u03b1 blockade with infliximab in refractory Wegener's granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.08-3043_bib61","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.0000124720.18538.DD","article-title":"Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation","volume":"109","author":"Booth","year":"2004","journal-title":"Circulation"},{"key":"10.1378\/chest.08-3043_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/ard.61.6.559","article-title":"Safety and efficacy of TNF\u03b1 blockade in relapsing vasculitis","volume":"61","author":"Booth","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2007.083584","article-title":"Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients","volume":"67","author":"Josselin","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib64","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/rheumatology\/kem229","article-title":"Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis","volume":"46","author":"Seymour","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.08-3043_bib65","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10067-006-0375-2","article-title":"Treatment of refractory temporal arteritis with adalimumab","volume":"26","author":"Ahmed","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1378\/chest.08-3043_bib66","first-page":"304","article-title":"Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab","volume":"24","author":"Tato","year":"2005","journal-title":"Int Angiol"},{"key":"10.1378\/chest.08-3043_bib67","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","article-title":"Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy","volume":"44","author":"Specks","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib68","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.08-3043_bib69","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib70","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations","volume":"65","author":"Aries","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib71","first-page":"S23","article-title":"Adjunction of rituximab to steroids and immunosuppressants for refractory\/relapsing Wegener's granulomatosis: a study on 8 patients","volume":"25","author":"Brihaye","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1378\/chest.08-3043_bib72","first-page":"2017","article-title":"Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations","volume":"35","author":"Seo","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib73","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","article-title":"Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab","volume":"45","author":"Stasi","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.08-3043_bib74","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/keh009","article-title":"Maintenance of remission with leflunomide in Wegener's granulomatosis","volume":"43","author":"Metzler","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.08-3043_bib75","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kem029","article-title":"Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis","volume":"46","author":"Metzler","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1378\/chest.08-3043_bib76","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1159\/000065581","article-title":"A case of Wegener's granulomatosis treated with mycophenolate mofetil","volume":"92","author":"Lin","year":"2002","journal-title":"Nephron"},{"key":"10.1378\/chest.08-3043_bib77","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/S0272-6386(99)70095-8","article-title":"Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil","volume":"34","author":"Waiser","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1378\/chest.08-3043_bib78","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/ndt\/gfi117","article-title":"A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis","volume":"20","author":"Joy","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1378\/chest.08-3043_bib79","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2006.060301","article-title":"Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide","volume":"66","author":"Stassen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib80","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ndt\/gfm780","article-title":"Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement","volume":"23","author":"Hu","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1378\/chest.08-3043_bib81","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-3043_bib82","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1378\/chest.08-3043_bib83","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","article-title":"Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients","volume":"65","author":"Schmitt","year":"2004","journal-title":"Kidney Int"},{"key":"10.1378\/chest.08-3043_bib84","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/ard.2008.092429","article-title":"Deoxyspergualin in relapsing and refractory Wegener's granulomatosis","author":"Flossmann","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-129-5-199809010-00004","article-title":"Interferon-\u03b1 treatment of four patients with the Churg-Strauss syndrome","volume":"129","author":"Tatsis","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-3043_bib86","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1398-9995.2003.00424.x","article-title":"Clinical and immunological effects of low-dose IFN-\u03b1 treatment in patients with corticosteroid-resistant asthma","volume":"58","author":"Simon","year":"2003","journal-title":"Allergy"},{"key":"10.1378\/chest.08-3043_bib87","first-page":"136","article-title":"Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement","volume":"137","author":"Termeer","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1378\/chest.08-3043_bib88","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1196\/annals.1423.028","article-title":"Current state of biologicals in the management of systemic vasculitis","volume":"1110","author":"Lamprecht","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1378\/chest.08-3043_bib89","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-3476(87)80007-0","article-title":"High-dose gammaglobulin therapy for Kawasaki disease","volume":"110","author":"Nagashima","year":"1987","journal-title":"J Pediatr"},{"key":"10.1378\/chest.08-3043_bib90","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/rheumatology\/35.11.1150","article-title":"Intravenous immunoglobulin as sole therapy for systemic vasculitis","volume":"35","author":"Jayne","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib91","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00007611-199904000-00012","article-title":"Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins","volume":"92","author":"Levy","year":"1999","journal-title":"South Med J"},{"key":"10.1378\/chest.08-3043_bib92","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"key":"10.1378\/chest.08-3043_bib93","first-page":"309","article-title":"Wegener's granulomatosis: survey of 701 patients in North America: changes in outcome in the 1990s","volume":"29","author":"Abdou","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib94","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2008.099051","article-title":"High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients","volume":"68","author":"Allenbach","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-3043_bib95","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-3043_bib96","first-page":"492","article-title":"Induction of remission in Wegener's granulomatosis with low dose methotrexate","volume":"25","author":"de Groot","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.08-3043_bib97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"Wegener's Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-3043_bib98","author":"Oxford Centre for Evidence-Based Medicine"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369209606103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369209606103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T22:30:55Z","timestamp":1633991455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369209606103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0012369209606103"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-3043","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}